Skip main navigation

Main contents starts here

More about Bray

Takeda Ireland Limited (Bray) has played a key role in the group's worldwide operations since being established in 1997. A wholly-owned subsidiary of Takeda Pharmaceutical Company Limited, we began manufacturing in Ireland following the opening of our custom-built premises in Bray, Co. Wicklow in 1999. Since the first shipment of BLOPRESS/AMIAS in September of that year, we have served as Takeda's main Pharmaceutical production base for the European and U.S. markets. This early success was quickly followed by the construction of a new plant to enable the manufacture of Takeda's largest selling product (Lansoprazole). This facility was completed in 2000. As a dynamic and growing pharmaceutical company that is committed to improving the health and quality of life of people around the world. We put people first - both the patients we serve through researching and developing superior products, and the employees who share our passion for making a difference.

Company History & Future Plan
1997: Takeda Ireland Limited established
1997: Manufacturing Licence and GMP Certificate obtained from Irish Medicines Board (IMB)
1998: Construction of new facility commenced
1999: First commercial shipments
2000: FDA approval
2000: Completion of new facility and equipment validation.
2003: Completion of new Film Coating Line
2004: Completion of Warehouse and Laboratory Expansion
2004: Completion of new Packaging Line
2005: Completion of new Manufacturing Facility
2006: Completion of new Packaging Line
2007: Completion of new Laboratory
2009: Completion of new Canteen
2009: Integration of Takeda Pharma Ireland Ltd. into Takeda Ireland Ltd. (Grange Castle)
2011: Completion of new Packaging Line

Corporate Data
Established: October 1997
Business: Solid oral dosage finished pharmaceuticals
Facilities: 21,000 m2 formulation and packaging facility

Skip side navigation


Skip sub navigation

Page Top